The Gemma 4 model family can handle complex logic and agentic workflows, with the largest models, such as the 31B model, ...

Jeffrey S. Solochek is an education reporter covering K-12 education policy and schools. Reach him at [email protected]. Anyone can view a sampling of recent comments, but you must be a Times ...

This is read by an automated voice. Please report any issues or inconsistencies here. L.A. Unified high school students enrollment in Advanced Placement courses and passing scores have showed marked ...

LAUSD Supt.Alberto Carvalho announces district-wide gains in Advanced Placement course enrollment and test performance. (Christina House/Los Angeles Times) Los Angeles Unified high school students ...

Physician-assessed confirmed ORR reached 44% (18/41) with 73% disease control, suggesting robust activity in checkpoint- and targeted-refractory advanced melanoma. Comparative context showed higher ...

North American pay–radio operator SiriusXM has agreed a settlement of a Class Action lawsuit. SiriusXM will pay out $28 million (€23.7m) to settle the problem. SiriusXM denied wrongdoing in the ...

Evidence suggests the ancients may have possessed advanced techniques that defy conventional explanations. WH official to MS NOW: Trump told AG Bondi she'll 'soon be removed' Dietitians say you ...

"We showed that our method captures the right physics at high accuracy. There are now other advanced methods we'd like to integrate into the approach to keep improving it." The researchers envision ...

Ayyoun is a staff writer who loves all things gaming and tech. His journey into the realm of gaming began with a PlayStation 1 but he chose PC as his platform of choice. With over 6 years of ...

HAYWARD, Calif.--(BUSINESS WIRE)--Rondo Therapeutics, a clinical-stage biopharmaceutical company pioneering next-generation T-cell engaging bispecific antibodies for solid tumors, today announced that ...

What Is Imdelltra, and Why Does It Matter? Imdelltra (tarlatamab-dlle) is a first-of-its kind targeted cancer medicine called a bispecific T-cell engager approved for treating adults with ...